The union government has approved Bharat Biotech's intranasal vaccine, iNCOVACC. It will be used as a heterologous booster & will be available first in private hospitals. It will be included in COVID vaccination program from today, official sources have told the media.The union government has approved Bharat Biotech's intranasal vaccine, iNCOVACC. It will be used as a heterologous booster & will be available first in private hospitals. It will be included in COVID vaccination program from today, official sources have told the media.
Comments
Post a Comment